N-[3-(aminomethyl)-3-phenylcyclobutyl]-5,6,7,8-tetrahydroindolizine-1-carboxamide hydrochloride
Structure Info
- Chemspace ID
- CSSB20620691679 (In-Stock Building Blocks)
- CAS
- 3079608-27-5
- IUPAC Name
- N-[3-(aminomethyl)-3-phenylcyclobutyl]-5,6,7,8-tetrahydroindolizine-1-carboxamide hydrochloride
- Mol formula
- C20H26ClN3O
- Mol weight
- 360 Da
- Catalog Number(s)
- BBLS20620691679, EN300-52473418, bbls20620691679
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.29
- Heavy atoms count
- 25
- Rotatable bond count
- 4
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.45
- Polar surface area (Å)
- 60
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 2
![Chemical structure of N-[3-(aminomethyl)-3-phenylcyclobutyl]-5,6,7,8-tetrahydroindolizine-1-carboxamide hydrochloride (C20H26ClN3O) - CSSB20620691679](/st/structure/200/b83d62865b7d2c28d31aa799f0c56be8/Cl.NCC1%2528CC%2528C1%2529NC%2528%253DO%2529C1%253DC2CCCCN2C%253DC1%2529C1%253DCC%253DCC%253DC1.png "C20H26ClN3O")
- Zoom the structure
- CSSB20620691679
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 1,296.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 1,359.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,419.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,482.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,543.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 3,025.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 4,475.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 6,635.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[(1r,3r)-3-(aminomethyl)-3-phenylcyclobutyl]-5,6,7,8-tetrahydroindolizine-1-carboxamide hydrochloride - CSSB00161162814](/st/structure/200/cd1a9da8e64d310c75b40dec1b71a290/Cl.NC%255BC%2540%255D1%2528C%255BC%2540%2540H%255D%2528C1%2529NC%2528%253DO%2529C1%253DC2CCCCN2C%253DC1%2529C1%253DCC%253DCC%253DC1.png)
Similarity Analogs
![Chemical structure of N-[(1r,3r)-3-(aminomethyl)-3-phenylcyclobutyl]-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-2-carboxamide hydrochloride - CSSB00161164526](/st/structure/200/48753e0cc0c8de7ed84e8ced921367c3/Cl.NC%255BC%2540%255D1%2528C%255BC%2540%2540H%255D%2528C1%2529NC%2528%253DO%2529C1%253DCC2%253DC%2528CCCCC2%2529S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[3-(aminomethyl)-3-phenylcyclobutyl]-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-2-carboxamide hydrochloride - CSSB20620693747](/st/structure/200/20215fbd36a253d1437db866ce059284/Cl.NCC1%2528CC%2528C1%2529NC%2528%253DO%2529C1%253DCC2%253DC%2528CCCCC2%2529S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[3-(aminomethyl)-3-phenylcyclobutyl]-2-(2-ethylpyrrolidin-1-yl)-2-oxoacetamide hydrochloride - CSSB20620694213](/st/structure/200/135705b95603648ff192dbe1f8396bfc/Cl.CCC1CCCN1C%2528%253DO%2529C%2528%253DO%2529NC1CC%2528CN%2529%2528C1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 2-(2-ethylpyrrolidin-1-yl)-2-oxo-N-[(1r,3r)-3-(aminomethyl)-3-phenylcyclobutyl]acetamide hydrochloride - CSSB00161161564](/st/structure/200/12654046778be6b1a763b9cb490e8b09/Cl.CCC1CCCN1C%2528%253DO%2529C%2528%253DO%2529N%255BC%2540H%255D1C%255BC%2540%255D%2528CN%2529%2528C1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 3-cyclopentyl-1-methyl-N-[(1r,3r)-3-(aminomethyl)-3-phenylcyclobutyl]-1H-pyrazole-4-carboxamide hydrochloride - CSSB00161156690](/st/structure/200/473b176195a61ce9e55464f3a1f412a9/Cl.CN1C%253DC%2528C%2528%253DO%2529N%255BC%2540H%255D2C%255BC%2540%255D%2528CN%2529%2528C2%2529C2%253DCC%253DCC%253DC2%2529C%2528%253DN1%2529C1CCCC1.png)
![Chemical structure of N-[3-(aminomethyl)-3-phenylcyclobutyl]-3-cyclopentyl-1-methyl-1H-pyrazole-4-carboxamide hydrochloride - CSSB20620692006](/st/structure/200/38274eb1ece34ad131385c8bad9fbe0f/Cl.CN1C%253DC%2528C%2528%253DO%2529NC2CC%2528CN%2529%2528C2%2529C2%253DCC%253DCC%253DC2%2529C%2528%253DN1%2529C1CCCC1.png)
